<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007547.ref031">
 <label>31</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Barnea</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Melamed</surname>
   <given-names>KD</given-names>
  </name>, 
  <name>
   <surname>Haimovich</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Satumtira</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Dorris</surname>
   <given-names>ML</given-names>
  </name>, 
  <name>
   <surname>Nguyen</surname>
   <given-names>MT</given-names>
  </name>, 
  <name>
   <surname>Hammer</surname>
   <given-names>RE</given-names>
  </name>, 
  <name>
   <surname>Tran</surname>
   <given-names>TM</given-names>
  </name>, 
  <name>
   <surname>Colbert</surname>
   <given-names>RA</given-names>
  </name>, 
  <name>
   <surname>Taurog</surname>
   <given-names>JD</given-names>
  </name>, 
  <name>
   <surname>Admon</surname>
   <given-names>A</given-names>
  </name> (
  <year>2017</year>) 
  <article-title>The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion</article-title>. 
  <source>Mol Cell Proteomics</source>
  <volume>16</volume>: 
  <fpage>642</fpage>â€“
  <lpage>662</lpage>. M116.066241 [pii]; 
  <pub-id pub-id-type="doi">10.1074/mcp.M116.066241</pub-id>
  <?supplied-pmid 28188227?>
  <pub-id pub-id-type="pmid">28188227</pub-id>
 </mixed-citation>
</ref>
